Advancements in the radiooncological treatment of high-risk prostate cancer: a quarter century of achievements

Advancements in the radiooncological treatment of high-risk prostate cancer: a quarter century of achievements

The aim of the study was to evaluate the development of treatment of primary high-risk prostate cancer in regards to biochemical no evidence of disease (bNED), acute and late gastrointestinal (GI) and genitourinary (GU) side effects.

Bibliographic Details
Main Authors: Moll Matthias, Herrmann Harald, Zaharie Alexandru, Goldner Gregor
Format: Article
Language:English
Published: Sciendo 2022-08-01
Series:Radiology and Oncology
Subjects:
biochemical control
gastrointestinal toxicity
genitourinary toxicity
dose escalation
Online Access:https://doi.org/10.2478/raon-2022-0018

Internet

https://doi.org/10.2478/raon-2022-0018

Similar Items